BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8720679)

  • 1. Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?
    Loeffler KU; Bräutigam P; Simon JC; Althauser SR; Wuttig C; Witschel H
    Graefes Arch Clin Exp Ophthalmol; 1996 Feb; 234(2):100-4. PubMed ID: 8720679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antigen pattern in choroid melanoma in correlation with immunoscintigraphy].
    Löffler KU; Simon JC; Wuttig C; Althauser SR; Bräutigam P; Witschel H
    Ophthalmologe; 1995 Oct; 92(5):723-7. PubMed ID: 8751005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma].
    Löffler KU; Bräutigam P; Simon J; Althauser SR; Moser E; Witschel H
    Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy with three step monoclonal pretargeting technique in diagnosis of uveal melanoma: preliminary results.
    Modorati G; Brancato R; Paganelli G; Magnani P; Pavoni R; Fazio F
    Br J Ophthalmol; 1994 Jan; 78(1):19-23. PubMed ID: 8110692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-melanoma immunoscintigraphy].
    Santos AI; Godinho F
    Acta Med Port; 1995 Jan; 8(1):49-55. PubMed ID: 7747612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry.
    Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E
    Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
    Rosanowski F; Briele B; Walther EK
    Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest.
    Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A
    J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subretinal tumour in a patient with a limited form of Wegener's granulomatosis.
    Agostini HT; Bräutigam P; Löffler KU
    Acta Ophthalmol Scand; 1995 Oct; 73(5):460-3. PubMed ID: 8751130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscintigraphy in malignant melanoma: a five-year clinical experience.
    Feggi L; Indelli M; Pansini GC; Santini A; Prandini N; Virgili AR
    Nucl Med Commun; 1993 Feb; 14(2):145-8. PubMed ID: 8429994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
    Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
    Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results.
    Schaling DF; van der Pol JP; Jager MJ; van Kroonenburgh MJ; Oosterhuis JA; Ruiter DJ
    Br J Ophthalmol; 1990 Sep; 74(9):538-41. PubMed ID: 2203468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.
    Bomanji J; Hungerford JL; Granowska M; Britton KE
    Br J Ophthalmol; 1987 Sep; 71(9):651-8. PubMed ID: 2822079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
    Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
    Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with 99mTc labelled F(ab')2 fragments of an anti melanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma.
    Cerny T; Owens SE; Mackenzie SA; Nuttall PM; Gosh AK; Smith DB; Thatcher N
    Eur J Nucl Med; 1987; 13(3):130-3. PubMed ID: 3622556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.
    Schaling DF; Oosterhuis JA; Jager MJ; Kakebeeke-Kemme H; Pauwels EK
    Br J Ophthalmol; 1994 Apr; 78(4):244-8. PubMed ID: 8199106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
    Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
    Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of ocular melanoma with cutaneous melanoma antibodies.
    Bomanji J; Garner A; Prasad J; Albert DM; Hungerford JL; Granowska M; Britton KE
    Br J Ophthalmol; 1987 Sep; 71(9):647-50. PubMed ID: 3311140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Values and limitations of radioimmunoscintigraphy with MoAb 225-28S in the diagnosis of posterior uveal melanoma].
    Cavazza S; Tassoni A; Abbati A
    J Fr Ophtalmol; 1992; 15(6-7):395-9. PubMed ID: 1294595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical role of immunoscintigraphy for the detection of ocular melanoma.
    Schaling DF; Pauwels EK
    Q J Nucl Med; 1996 Dec; 40(4):335-40. PubMed ID: 9050338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.